Atacand HCT 32 12 5http://www.unboundmedicine.com/medline/ebm/research/Atacand_HCT_32_12_5Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy.http://www.unboundmedicine.com/medline/ebm/record/19203019/full_citation/Antihypertensive_efficacy_and_tolerability_of_candesartan_hydrochlorothiazide_32/12_5_mg_and_32/25_mg_in_patients_not_optimally_controlled_with_candesartan_monotherapy_Bönner G 
Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy. [Journal Article, Research Support, Non-U.S. Gov't]
Blood Press Suppl 2008 Dec.:22-30.
Abstract | Full CitationAntihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy.http://www.unboundmedicine.com/medline/ebm/record/19085342/full_citation/Antihypertensive_efficacy_and_tolerability_of_candesartan_hydrochlorothiazide_32/12_5_mg_and_32/25_mg_in_patients_not_optimally_controlled_with_candesartan_monotherapy_Bönner G 
Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy. [Journal Article, Research Support, Non-U.S. Gov't]
Blood Press 2008.:22-30.
Abstract | Full Citation | Find Related Articles